When Maryland plaintiffs agreed with drugmaker GlaxoSmithKline to toll the statute of limitations in their cases, their accord did not extend the time to begin lawsuits in Pennsylvania, the state Superior Court ruled in an unpublished opinion last month.
The plaintiffs in Collins v. SmithKline Beecham Corp. argued that the agreement, struck on Jan. 10, 2005, with GlaxoSmithKline, applied both to Pennsylvania’s two-year statute of limitations and Maryland’s three-year statute, the opinion said.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
